WNT5A and type 2 diabetes mellitus: Overactivation of Wnt5a/PCP pathway is also detected in ECs from patients with T2DM, thus inhibiting this signalling could ameliorate insulin resistance and dysfunction of ECs from T2DM patients.78, 89